TriSalus Life Sciences, Inc. TLSI Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $45.15M+53.4% | $29.43M+59.0% | $18.51M— | —— | ||
| $6.97M+69.8% | $4.1M+57.5% | $2.61M— | —— | ||
| $38.19M+50.8% | $25.33M+59.2% | $15.91M— | —— | ||
| 84.6%-1.5pp | 86.1%+0.1pp | 85.9%— | —— | ||
| $14.69M-16.9% | $17.69M-40.7% | $29.8M— | —— | ||
| $28.71M+11.1% | $25.84M+51.7% | $17.03M— | —— | ||
| $21.73M+21.0% | $17.97M-23.5% | $23.49M+176% | $8.51M+180% | ||
| -$26.95M+25.5% | -$36.17M+33.5% | -$54.42M-161% | -$20.84M-585% | ||
| -59.7%+63.2pp | -122.9%+171pp | -294%— | —— | ||
| $5.54M+79.4% | $3.09M+19,213% | $16K— | —— | ||
| -$456K-46.2% | -$312K-155% | $565.04K-93.6% | $8.86M+13.4% | ||
| -$39.22M-30.6% | -$30.04M+49.3% | -$59.3M-134% | -$25.38M-594% | ||
| $7K— | —— | $9K— | —— | ||
| -$39.23M-30.6% | -$30.05M+49.4% | -$59.36M-25.8% | -$47.19M-1,090% | ||
| -86.9%+15.2pp | -102.1%+219pp | -320.7%— | —— | ||
| -$1.74-30.8% | -$1.33+96.5% | -$37.60+64.2% | -$105.16-70,207% | ||
| -$26.32M+25.7% | -$35.42M+34.1% | -$53.74M-163% | -$20.44M— | ||
| -58.3%+62.1pp | -120.4%+170pp | -290.3%— | —— | ||
| -$26.95M+25.5% | -$36.17M+33.5% | -$54.42M-161% | -$20.84M-585% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is TriSalus Life Sciences, Inc.'s revenue?
- TriSalus Life Sciences, Inc. (TLSI) generated $44.9M in revenue over the trailing twelve months, up 39.6% year over year.
- Is TriSalus Life Sciences, Inc. profitable?
- TriSalus Life Sciences, Inc. is not currently profitable: it reported a net loss of $27.3M over the trailing twelve months, a -60.9% net margin.
- What are TriSalus Life Sciences, Inc.'s profit margins?
- Gross margin is 85.1% and operating margin is -62.4%, with a -60.9% net margin.
- What is TriSalus Life Sciences, Inc.'s earnings per share?
- TriSalus Life Sciences, Inc.'s diluted EPS over the trailing twelve months is $-1.32.
- Where does TriSalus Life Sciences, Inc.'s income statement data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
